EBR Systems Secures Preliminary Approval for US Medicare Reimbursement Scheme

MT Newswires Live

2025/07/15

EBR Systems (ASX:EBR) said the US Centers for Medicare & Medicaid Services provided preliminary approval for the transitional pass-through reimbursement scheme for the firm's proprietary Wireless Stimulation Endocardially cardiac resynchronization therapy system, according to a Tuesday Australian bourse filing.

The preliminary approval is expected to become effective in October and will be effective for three years.

The firm said it will continue to engage with the agency through the upcoming annual rulemaking and public comment process.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2551349281"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551349281\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2551349281?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-15 09:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551349281","market":"us","top_or_hot":-1,"title":"EBR Systems Secures Preliminary Approval for US Medicare Reimbursement Scheme","media":"MT Newswires Live","content":"<html><body><p> EBR Systems (ASX:EBR) said the US Centers for Medicare &amp; Medicaid Services provided preliminary approval for the transitional pass-through reimbursement scheme for the firm's proprietary Wireless Stimulation Endocardially cardiac resynchronization therapy system, according to a Tuesday Australian bourse filing.</p><p>The preliminary approval is expected to become effective in October and will be effective for three years.</p><p>The firm said it will continue to engage with the agency through the upcoming annual rulemaking and public comment process.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EBR Systems Secures Preliminary Approval for US Medicare Reimbursement Scheme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEBR Systems Secures Preliminary Approval for US Medicare Reimbursement Scheme\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-07-15 09:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> EBR Systems (ASX:EBR) said the US Centers for Medicare &amp; Medicaid Services provided preliminary approval for the transitional pass-through reimbursement scheme for the firm's proprietary Wireless Stimulation Endocardially cardiac resynchronization therapy system, according to a Tuesday Australian bourse filing.</p><p>The preliminary approval is expected to become effective in October and will be effective for three years.</p><p>The firm said it will continue to engage with the agency through the upcoming annual rulemaking and public comment process.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4081","symbol_name":"電力公用事業","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2551349281","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551349281","pubTimestamp":1752542524,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EBR Systems  said the US Centers for Medicare & Medicaid Services provided preliminary approval for the transitional pass-through reimbursement scheme for the firm's proprietary Wireless Stimulation Endocardially cardiac resynchronization therapy system, according to a Tuesday Australian bourse filing.The preliminary approval is expected to become effective in October and will be effective for three years.The firm said it will continue to engage with the agency through the upcoming annual rulemaking and public comment process.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4081":"电力公用事业","BK7007":"医疗保健设备","EBR.AU":"EBR SYSTEMS INC-CDI","IE00B1B80R65.USD":"柏瑞拉丁美洲股票A"},"translate_title":"EBR Systems获得美国医疗保险报销计划的初步批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBR":1,"EBR.AU":0.9},"content_text":"EBR Systems (ASX:EBR) said the US Centers for Medicare & Medicaid Services provided preliminary approval for the transitional pass-through reimbursement scheme for the firm's proprietary Wireless Stimulation Endocardially cardiac resynchronization therapy system, according to a Tuesday Australian bourse filing.The preliminary approval is expected to become effective in October and will be effective for three years.The firm said it will continue to engage with the agency through the upcoming annual rulemaking and public comment process.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}